These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 28929048)

  • 1. Brand versus generic dispensing trend for ciprofloxacin 500 mg, levofloxacin 500 mg, and moxifloxacin 400 mg (oral dosage forms) among pharmacies of Karachi, Pakistan.
    Zehra F; Naqvi AA; Tasneem S; Ahmad R; Ahmad N; Shamsi AZ; Asghar NA; Khan GU
    Int J Pharm Investig; 2017; 7(2):70-76. PubMed ID: 28929048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of generic competition on the price of brand-name drugs.
    Lexchin J
    Health Policy; 2004 Apr; 68(1):47-54. PubMed ID: 15033552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perception and attitude of general practitioners regarding generic medicines in Karachi, Pakistan: A questionnaire based study.
    Jamshed SQ; Ibrahim MI; Hassali MA; Masood I; Low BY; Shafie AA; Babar ZU
    South Med Rev; 2012 Jul; 5(1):22-30. PubMed ID: 23093896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of the Minimum Pricing Policy and introduction of brand (generic) substitution into the Pharmaceutical Benefits Scheme in Australia.
    McManus P; Birkett DJ; Dudley J; Stevens A
    Pharmacoepidemiol Drug Saf; 2001; 10(4):295-300. PubMed ID: 11760489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of authorized generic marketing with prescription drug spending on antidepressants from 2000 to 2011.
    Cheng N; Banerjee T; Qian J; Hansen RA
    J Am Pharm Assoc (2003); 2017; 57(3):341-348. PubMed ID: 28400255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do higher-priced generic medicines enjoy a competitive advantage under reference pricing?
    Puig-Junoy J
    Appl Health Econ Health Policy; 2012 Nov; 10(6):441-51. PubMed ID: 22900924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreasing utilization and increasing prices of brand-name oral contraceptive pills: Implications to societal costs and market competition.
    Zhang JX
    PLoS One; 2020; 15(6):e0234463. PubMed ID: 32525965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating drug prices, availability, affordability, and price components: implications for access to drugs in Malaysia.
    Babar ZU; Ibrahim MI; Singh H; Bukahri NI; Creese A
    PLoS Med; 2007 Mar; 4(3):e82. PubMed ID: 17388660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. WHO key access antibiotics price, availability and affordability in private sector pharmacies in Pakistan.
    Saleem Z; Saeed H; Akbar Z; Saeed A; Khalid S; Farrukh L; Irfan A; Anam A; Hassali MA; Rasheed H; Babar ZU
    Cost Eff Resour Alloc; 2021 Feb; 19(1):10. PubMed ID: 33593366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reference pricing with endogenous generic entry.
    Brekke KR; Canta C; Straume OR
    J Health Econ; 2016 Dec; 50():312-329. PubMed ID: 27350294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emergence of high-level fluoroquinolone resistance in emm6 Streptococcus pyogenes and in vitro resistance selection with ciprofloxacin, levofloxacin and moxifloxacin.
    Malhotra-Kumar S; Van Heirstraeten L; Lammens C; Chapelle S; Goossens H
    J Antimicrob Chemother; 2009 May; 63(5):886-94. PubMed ID: 19279051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of sunitinib in combination with fluoroquinolones in rabbit model.
    Szałek E; Karbownik A; Grabowski T; Sobańska K; Wolc A; Grześkowiak E
    Pharmacol Rep; 2013; 65(5):1383-90. PubMed ID: 24399735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioequivalence and in vitro antimicrobial activity between generic and brand-name levofloxacin.
    Sun HY; Liao HW; Sheng MH; Tai HM; Kuo CH; Sheng WH
    Diagn Microbiol Infect Dis; 2016 Jul; 85(3):347-351. PubMed ID: 27181716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prices & availability of common medicines at six sites in India using a standard methodology.
    Kotwani A; Ewen M; Dey D; Iyer S; Lakshmi PK; Patel A; Raman K; Singhal GL; Thawani V; Tripathi S; Laing R
    Indian J Med Res; 2007 May; 125(5):645-54. PubMed ID: 17642500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Price difference as a predictor of the selection between brand name and generic statins in Japan.
    Takizawa O; Urushihara H; Tanaka S; Kawakami K
    Health Policy; 2015 May; 119(5):612-9. PubMed ID: 25697888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of oral ciprofloxacin, levofloxacin, ofloxacin and moxifloxacin with the risk of serious ventricular arrhythmia: a nationwide cohort study in Korea.
    Cho Y; Park HS
    BMJ Open; 2018 Sep; 8(9):e020974. PubMed ID: 30269062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Moxifloxacin versus levofloxacin or ciprofloxacin prophylaxis in acute myeloid leukemia patients receiving chemotherapy.
    Przybylski DJ; Reeves DJ
    Support Care Cancer; 2017 Dec; 25(12):3715-3721. PubMed ID: 28660351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Community pharmacists' attitudes toward the quality and price of locally manufactured generic medicines in Kabul, Afghanistan.
    Bashaar M; Hassali MA; Saleem F
    J Pharm Policy Pract; 2015; 8(1):16. PubMed ID: 26078869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dichotomous selection of high-level oxacillin resistance in Staphylococcus aureus by fluoroquinolones.
    Dalhoff A; Schubert S
    Int J Antimicrob Agents; 2010 Sep; 36(3):216-21. PubMed ID: 20630710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. OSTEOPOROSIS DRUGS MARKETED IN THE UNITED STATES: GENERIC COMPETITION, PRICING STRUCTURE, AND DISPERSION AMONG PAYERS.
    Balkhi B; Seoane-Vazquez E; Rodriguez-Monguio R
    Int J Technol Assess Health Care; 2016 Jan; 32(6):385-392. PubMed ID: 28065194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.